UGT1A7 Antibodies

Santa Cruz Biotechnology delivers a wide array of UGT1A7 monoclonal antibodies for research focused on understanding this important protein. UGT1A7 Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UGT1A7 is a member of the UDP-glucuronosyltransferase family, which plays a crucial role in the metabolism of various endogenous and exogenous compounds, including drugs and toxins. By facilitating the conjugation of glucuronic acid to substrates, UGT1A7 helps in detoxification and elimination processes, making it vital for maintaining homeostasis in the body. Understanding the function and regulation of UGT1A7 is essential for elucidating its impact on drug metabolism and potential implications in pharmacogenomics. Research utilizing UGT1A7 monoclonal antibodies can reveal new insights into drug metabolism pathways and therapeutic responses. Investigating UGT1A7 expression patterns helps researchers better understand its role in various physiological and pathological conditions. Studies focusing on UGT1A7 contribute to developing more effective therapeutic strategies and personalized medicine approaches. Santa Cruz Biotechnology monoclonal antibodies for UGT1A7 support researchers worldwide in advancing scientific understanding of drug metabolism and therapeutic development.